carnitine has been researched along with Arrhythmias, Cardiac in 46 studies
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The antiarrhythmic effect of L-propionylcarnitine (L-PC) was evaluated in the guinea-pig isolated heart; arrhythmias were induced with hypoxia followed by reoxygenation and by digitalis intoxication." | 7.68 | Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties. ( Barbieri, M; Carbonin, PU; Cerbai, E; Gambassi, G; Lo Giudice, P; Masini, I; Mugelli, A; Pahor, M, 1991) |
| "Long chain acyl carnitines, intermediates of free fatty acid metabolism, have been implicated in malignant arrhythmias occurring during myocardial ischaemia." | 7.67 | Mechanism of arrhythmias induced by palmitylcarnitine in guinea pig papillary muscle. ( Hayashi, H; Kobayashi, A; Sakata, K; Yamazaki, N, 1989) |
| "The therapeutic effect of L-carnitine on arrhythmias during hemodialysis was evaluated in 17 patients with chronic renal disease undergoing intermittent hemodialysis." | 7.66 | Effects of L-carnitine on arrhythmias during hemodialysis. ( Narita, M; Suzuki, Y; Yamazaki, N, 1982) |
| "Effects of L-carnitine on ventricular arrhythmias and myocardial metabolism in a reperfused ischemic myocardium were studied in 35 anesthetized mongrel dogs." | 7.66 | Effects of L-carnitine on ventricular arrhythmias after coronary reperfusion. ( Abe, M; Hayashi, H; Kamikawa, T; Kobayashi, A; Masumura, Y; Nishihara, K; Suzuki, Y; Yamazaki, N, 1983) |
| "The effects of L-carnitine on ventricular arrhythmias were evaluated in dogs with acute myocardial ischemia and a supplement of excess free fatty acids (FFA)." | 7.66 | Effects of L-carnitine on ventricular arrhythmias in dogs with acute myocardial ischemia and a supplement of excess free fatty acids. ( Kamikawa, T; Suzuki, Y; Yamazaki, N, 1981) |
| "Carnitine is a natural substance essential for the mitochondrial oxidation of long-chain fatty acids and therefore regulates the energy metabolism of the cells." | 6.66 | [The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II]. ( Cantini, F; Digiesi, V; Palchetti, R, 1989) |
| "A systematic review and meta-analysis of 13 controlled trials (N=3629) was conducted to determine the effects of L-carnitine vs placebo or control on mortality, ventricular arrhythmias (VAs), angina, heart failure, and reinfarction." | 4.89 | L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. ( DiNicolantonio, JJ; Fares, H; Lavie, CJ; Menezes, AR; O'Keefe, JH, 2013) |
| "Carnitine and its derivatives have recently been shown to protect cardiac metabolism and function in ischemic heart disease and other clinical conditions of myocardial ischemia." | 4.81 | Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. ( Lango, R; Lysiak-Szydlowska, W; Narkiewicz, M; Smolenski, RT; Suchorzewska, J, 2001) |
| "Primary carnitine deficiency (PCD) affects fatty acid oxidation and is associated with cardiomyopathy and cardiac arrhythmia, but the risk of sudden death in PCD is unknown." | 3.96 | Increased risk of sudden death in untreated primary carnitine deficiency. ( Dunø, M; Hansen, SH; Joensen, HD; Køber, L; Lund, AM; Nielsen, OW; Rasmussen, J; Steuerwald, U, 2020) |
| "Carnitine deficiency can cause cardiomyopathy and cardiac arrhythmia." | 3.80 | Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening. ( Køber, L; Lund, AM; Nielsen, OW; Rasmussen, J, 2014) |
| "Exposure to antibiotics containing pivalic acid was associated with encephalopathy and progression to lethal cardiac arrhythmia in patients suffering from PCD." | 3.79 | Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. ( Djurhuus, H; Køber, L; Lund, AM; Nielsen, OW; Rasmussen, J, 2013) |
| "The accumulation of arrhythmogenic intermediary metabolites of fatty acids, such as long-chain acylcarnitines, may be responsible for arrhythmias." | 3.70 | Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. ( Bonnet, D; Brivet, M; Jouvet, P; Martin, D; Rabier, D; Saudubray, JM; Villain, E, 1999) |
| " Response of myocardial function to rapid intravenous infusion of saline 10 mL/kg/min and the times of onset of ventricular arrhythmias during intravenous infusion of aconitine 20 micrograms/kg/min were determined in anesthetized rats at week 12." | 3.69 | Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration. ( Battell, M; Dai, S; Lee, S; McNeill, JH, 1994) |
| " The antiarrhythmic effect of L-propionylcarnitine (L-PC) was evaluated in the guinea-pig isolated heart; arrhythmias were induced with hypoxia followed by reoxygenation and by digitalis intoxication." | 3.68 | Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties. ( Barbieri, M; Carbonin, PU; Cerbai, E; Gambassi, G; Lo Giudice, P; Masini, I; Mugelli, A; Pahor, M, 1991) |
| "Long chain acyl carnitines, intermediates of free fatty acid metabolism, have been implicated in malignant arrhythmias occurring during myocardial ischaemia." | 3.67 | Mechanism of arrhythmias induced by palmitylcarnitine in guinea pig papillary muscle. ( Hayashi, H; Kobayashi, A; Sakata, K; Yamazaki, N, 1989) |
| "Though the efficacies of procainamide and disopyramide in treating arrhythmias are well established, their precise mechanisms of antiarrhythmic action remain unclear." | 3.67 | Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart. ( Kobayashi, A; Watanabe, H; Yamazaki, N, 1988) |
| "The therapeutic effect of L-carnitine on arrhythmias during hemodialysis was evaluated in 17 patients with chronic renal disease undergoing intermittent hemodialysis." | 3.66 | Effects of L-carnitine on arrhythmias during hemodialysis. ( Narita, M; Suzuki, Y; Yamazaki, N, 1982) |
| "Effects of L-carnitine on ventricular arrhythmias and myocardial metabolism in a reperfused ischemic myocardium were studied in 35 anesthetized mongrel dogs." | 3.66 | Effects of L-carnitine on ventricular arrhythmias after coronary reperfusion. ( Abe, M; Hayashi, H; Kamikawa, T; Kobayashi, A; Masumura, Y; Nishihara, K; Suzuki, Y; Yamazaki, N, 1983) |
| "It has been reported that long chain acyl carnitine accumulates in ischemic myocardium, and L-carnitine prevents ventricular arrhythmias as well as the accumulation of long chain acyl carnitine in ischemic and free fatty acid supplemented hearts." | 3.66 | Effects of L-carnitine on action potential or canine papillary muscle impaired by long chain acyl carnitine. ( Hayashi, H; Kamikawa, T; Kobayashi, A; Masumura, Y; Suzuki, Y; Yamazaki, N, 1982) |
| "The effects of L-carnitine on ventricular arrhythmias were evaluated in dogs with acute myocardial ischemia and a supplement of excess free fatty acids (FFA)." | 3.66 | Effects of L-carnitine on ventricular arrhythmias in dogs with acute myocardial ischemia and a supplement of excess free fatty acids. ( Kamikawa, T; Suzuki, Y; Yamazaki, N, 1981) |
| "Heart failure, fatal arrhythmias, and cardiac dilatation because of anemia are common causes of β-thalassemia major-related deaths." | 2.94 | The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia. ( Fattahi, N; Hashemi, SR; Moradveisi, B; Roshani, D; Shahidi, M; Sharifi, P; Vahedi, S, 2020) |
| "L-carnitine was randomly administered to 81 patients at an oral dose of g 4/die for 12 months, in addition to the pharmacological treatment generally used." | 2.67 | Controlled study on L-carnitine therapeutic efficacy in post-infarction. ( Bigalli, A; Boem, A; Davini, P; Lamanna, F, 1992) |
| "Carnitine is a natural substance essential for the mitochondrial oxidation of long-chain fatty acids and therefore regulates the energy metabolism of the cells." | 2.66 | [The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II]. ( Cantini, F; Digiesi, V; Palchetti, R, 1989) |
| "Brugada syndrome is an autosomal dominant trait with right bundle branch block and ST elevation." | 2.43 | Pathogenesis of cardiac conduction disorders in children genetic and histopathologic aspects. ( Barness, LA; Gilbert-Barness, E, 2006) |
| "Here, we report a case of sudden death in which a 10-year-old boy experienced cardiopulmonary arrest 5 min after receiving a Japanese encephalitis vaccination." | 1.42 | A case of sudden death after Japanese encephalitis vaccination. ( Akaza, K; Bunai, Y; Ishii, A; Nagai, A; Nishida, N; Yamaguchi, S, 2015) |
| " Long-term administration of L-carnitine increases the cardiac L-carnitine content in mice and has been shown to improve surrogate markers of coronary heart disease such as arrhythmias, nitrate consumption, and left ventricular dilatation and infarct size in patients after myocardial infarction." | 1.30 | [Physiologic bases for the use of L-carnitine in cardiology]. ( Krähenbühl, S, 1998) |
| "The effects of verapamil on ventricular arrhythmias and free fatty acids metabolism during coronary artery reperfusion in experimental dogs were evaluated over a period of 40 minutes and followed by reperfusion for 15 minutes." | 1.27 | Antiarrhythmic and myocardial metabolic effects of verapamil during coronary artery reperfusion. ( Abe, M; Hayashi, H; Ishizaka, K; Kamikawa, T; Kobayashi, A; Nagao, B; Nishiyama, T; Yamashita, T; Yamazaki, N, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (45.65) | 18.7374 |
| 1990's | 9 (19.57) | 18.2507 |
| 2000's | 4 (8.70) | 29.6817 |
| 2010's | 8 (17.39) | 24.3611 |
| 2020's | 4 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Gao, F | 2 |
| Rong, S | 1 |
| Chai, C | 1 |
| Yan, F | 1 |
| Zhao, X | 1 |
| Han, X | 1 |
| Yang, Z | 1 |
| Shahidi, M | 1 |
| Hashemi, SR | 1 |
| Fattahi, N | 1 |
| Roshani, D | 1 |
| Vahedi, S | 1 |
| Sharifi, P | 1 |
| Moradveisi, B | 1 |
| Almannai, M | 1 |
| Aldehaimi, A | 1 |
| Peake, RWA | 1 |
| Almontashiri, NAM | 1 |
| Wang, ZY | 1 |
| Liu, YY | 1 |
| Liu, GH | 1 |
| Lu, HB | 1 |
| Mao, CY | 1 |
| Rasmussen, J | 3 |
| Dunø, M | 1 |
| Lund, AM | 3 |
| Steuerwald, U | 1 |
| Hansen, SH | 1 |
| Joensen, HD | 1 |
| Køber, L | 3 |
| Nielsen, OW | 3 |
| Ascunce, RR | 1 |
| Nayar, AC | 1 |
| Phoon, CK | 1 |
| Srichai, MB | 1 |
| DiNicolantonio, JJ | 1 |
| Lavie, CJ | 1 |
| Fares, H | 1 |
| Menezes, AR | 1 |
| O'Keefe, JH | 1 |
| Balykova, LA | 1 |
| Shirokova, AA | 1 |
| Soldatov, OM | 1 |
| Shchekina, NV | 1 |
| Urziaeva, AN | 1 |
| Bunai, Y | 1 |
| Ishii, A | 1 |
| Akaza, K | 1 |
| Nagai, A | 1 |
| Nishida, N | 1 |
| Yamaguchi, S | 1 |
| Roussel, J | 1 |
| Labarthe, F | 1 |
| Thireau, J | 1 |
| Ferro, F | 1 |
| Farah, C | 1 |
| Roy, J | 1 |
| Horiuchi, M | 1 |
| Tardieu, M | 1 |
| Lefort, B | 1 |
| François Benoist, J | 1 |
| Lacampagne, A | 1 |
| Richard, S | 1 |
| Fauconnier, J | 1 |
| Babuty, D | 1 |
| Le Guennec, JY | 1 |
| Najafi, M | 1 |
| Garjani, A | 1 |
| Maleki, N | 1 |
| Eteraf Oskouei, T | 1 |
| Djurhuus, H | 1 |
| Feillet, F | 1 |
| Steinmann, G | 1 |
| Vianey-Saban, C | 1 |
| de Chillou, C | 1 |
| Sadoul, N | 1 |
| Lefebvre, E | 1 |
| Vidailhet, M | 1 |
| Bollaert, PE | 1 |
| Gilbert-Barness, E | 1 |
| Barness, LA | 1 |
| Tacconi, MT | 1 |
| Bonaccorsi, A | 1 |
| Cini, M | 1 |
| Spina, AM | 1 |
| Bizzi, A | 1 |
| Suzuki, Y | 4 |
| Narita, M | 1 |
| Yamazaki, N | 8 |
| Imai, S | 1 |
| Matsui, K | 1 |
| Nakazawa, M | 1 |
| Takatsuka, N | 1 |
| Takeda, K | 1 |
| Tamatsu, H | 1 |
| Corr, PB | 6 |
| Sobel, BE | 5 |
| Kobayashi, A | 6 |
| Kamikawa, T | 4 |
| Hayashi, H | 4 |
| Masumura, Y | 2 |
| Nishihara, K | 1 |
| Abe, M | 2 |
| Lee, BI | 1 |
| Sugiyama, S | 1 |
| Miyazaki, Y | 1 |
| Kotaka, K | 1 |
| Kato, T | 1 |
| Suzuki, S | 1 |
| Ozawa, T | 1 |
| Snyder, DW | 1 |
| Cain, ME | 1 |
| Crafford, WA | 1 |
| Gross, RW | 2 |
| Giordano, MP | 1 |
| Roncarolo, PL | 1 |
| Gabasio, CA | 1 |
| Corsi, M | 1 |
| Trevisani, C | 1 |
| Schiavoni, G | 1 |
| Lucente, M | 1 |
| Di Folca, A | 1 |
| Alessandri, N | 1 |
| Mongiardo, R | 1 |
| Manzoli, U | 1 |
| Yamada, KA | 1 |
| Dai, S | 1 |
| Lee, S | 1 |
| Battell, M | 1 |
| McNeill, JH | 1 |
| Arita, M | 1 |
| Sato, T | 1 |
| Ishida, H | 1 |
| Nakazawa, H | 1 |
| Mondillo, S | 1 |
| Faglia, S | 1 |
| D'Aprile, N | 1 |
| Mangiacotti, L | 1 |
| Campolo, MA | 1 |
| Agricola, E | 1 |
| Palazzuoli, V | 1 |
| Krähenbühl, S | 1 |
| Bonnet, D | 1 |
| Martin, D | 1 |
| Villain, E | 1 |
| Jouvet, P | 1 |
| Rabier, D | 1 |
| Brivet, M | 1 |
| Saudubray, JM | 1 |
| Lango, R | 1 |
| Smolenski, RT | 1 |
| Narkiewicz, M | 1 |
| Suchorzewska, J | 1 |
| Lysiak-Szydlowska, W | 1 |
| Davini, P | 1 |
| Bigalli, A | 1 |
| Lamanna, F | 1 |
| Boem, A | 1 |
| DaTorre, SD | 1 |
| Creer, MH | 1 |
| Pogwizd, SM | 1 |
| Barbieri, M | 1 |
| Carbonin, PU | 1 |
| Cerbai, E | 1 |
| Gambassi, G | 1 |
| Lo Giudice, P | 1 |
| Masini, I | 1 |
| Mugelli, A | 1 |
| Pahor, M | 1 |
| Sakata, K | 1 |
| Digiesi, V | 1 |
| Palchetti, R | 1 |
| Cantini, F | 1 |
| Watanabe, H | 1 |
| Saffitz, JE | 1 |
| Mortensen, SA | 1 |
| Aabo, K | 1 |
| Jonsson, T | 1 |
| Baandrup, U | 1 |
| Borum, PR | 1 |
| Taggart, EM | 1 |
| Nagao, B | 1 |
| Nishiyama, T | 1 |
| Yamashita, T | 1 |
| Ishizaka, K | 1 |
| Kamiya, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Acetyl L-Carnitine in Patients With Covid-19 Pneumonia[NCT04623619] | 100 participants (Anticipated) | Interventional | 2020-12-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for carnitine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
l-Carnitine and heart disease.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Carnitine; Heart; Heart Diseases; Humans; Myocard | 2018 |
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Carnitine; Heart Failure; Humans; Myocardial Infarction; Odds | 2013 |
Pathogenesis of cardiac conduction disorders in children genetic and histopathologic aspects.
Topics: Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Carnitine; Female; Heart Block; Heart Conduction | 2006 |
Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carnitine; Carnitine O-Palmitoyltransferase; | 1995 |
Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Cardiopulmonary Bypass; Carnitine; Energy Met | 2001 |
Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Electrophysiology; Humans; Lipid Metabol | 1991 |
Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart.
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Fatty Acids; Lysophospholipids; Myocardi | 1987 |
5 trials available for carnitine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; beta-Thalassemia; Carnitine; Case-Control Studies; Child; C | 2020 |
[Using L-carnitine to improve the adaptation of young athletes to physical load and the correction of stress-induced cardiomyopathy].
Topics: Adaptation, Physiological; Administration, Oral; Adolescent; Arrhythmias, Cardiac; Athletes; Atrial | 2014 |
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Carnitine; Drug Sy | 1995 |
Controlled study on L-carnitine therapeutic efficacy in post-infarction.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Carnitine; Fe | 1992 |
[The benefits of L-carnitine therapy in essential arterial hypertension with diabetes mellitus type II].
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Carnitine; Clinical Trials as Topic; Diabetes Mellitus, | 1989 |
34 other studies available for carnitine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Protective effect of L-carnitine on myocardium after PCI in patients with acute ST segment elevation myocardial infarction.
Topics: Arrhythmias, Cardiac; Carnitine; Humans; Myocardium; Percutaneous Coronary Intervention; ST Elevatio | 2023 |
Hyperammonemia, Lactic Acidosis, and Arrhythmia in a Newborn.
Topics: Acidosis, Lactic; Arrhythmias, Cardiac; Carnitine; Female; Humans; Hyperammonemia; Infant, Newborn; | 2021 |
Increased risk of sudden death in untreated primary carnitine deficiency.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiomyopathies; Carnitine; Child; Child, Preschool; Death | 2020 |
Cardiac magnetic resonance findings in a case of carnitine deficiency.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Carnitine; Contrast Media; Death, Sudden, Cardiac; Defibrill | 2013 |
Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiomyopathies; Carnitine; Denmark; Dietary Supplements; | 2014 |
A case of sudden death after Japanese encephalitis vaccination.
Topics: Anaphylaxis; Arrhythmias, Cardiac; Autopsy; C-Reactive Protein; Carnitine; Cause of Death; Child; De | 2015 |
Carnitine deficiency induces a short QT syndrome.
Topics: Adult; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Carnitine; Child, Preschool; Echocardiograph | 2016 |
Antiarrhythmic and arrhythmogenic effects of L-carnitine in ischemia and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carnitine; Coronary Occlusion; Epoxy Compound | 2008 |
Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events.
Topics: Adult; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiomyopathies; Carnitine; Child, Preschool; D | 2013 |
Adult presentation of MCAD deficiency revealed by coma and severe arrythmias.
Topics: Acyl-CoA Dehydrogenase; Adult; Arrhythmias, Cardiac; Carnitine; Coma; Critical Care; Dicarboxylic Ac | 2003 |
Effect of carnitine on heart alterations caused by tricyclic antidepressants.
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Heart; Male; Nortriptyline; Rabbits | 1981 |
Effects of L-carnitine on arrhythmias during hemodialysis.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Carnitine; Chronic Disease; Fatty A | 1982 |
Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function.
Topics: Acetylcarnitine; Adenosine Diphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood | 1984 |
Arrhythmogenic properties of phospholipid metabolites associated with myocardial ischemia.
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Electrophysiology; Glycerophosphates; He | 1983 |
Effects of L-carnitine on ventricular arrhythmias after coronary reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Coronary Vessels; Dogs; Ligation; Myocar | 1983 |
Electrophysiological and biochemical derangements in ischemic myocardium: interactions involving the cell membrane.
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Cats; Cell Membrane; Coronary Disease; Electrophysiology; | 1981 |
Mechanism of free fatty acid-induced arrhythmias.
Topics: Acetylcarnitine; Acyl Coenzyme A; Animals; Arrhythmias, Cardiac; Calcium; Carnitine; Dogs; Fatty Aci | 1982 |
Effects of L-carnitine on action potential or canine papillary muscle impaired by long chain acyl carnitine.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Carnitine; Dogs; Fatty Acids, Nonesterified; In Vi | 1982 |
Effects of L-carnitine on ventricular arrhythmias in dogs with acute myocardial ischemia and a supplement of excess free fatty acids.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Carnitine; Dogs; Fatty Acids, Nonesterified; | 1981 |
Electrophysiological effects of amphiphiles on canine purkinje fibers. Implications for dysrhythmia secondary to ischemia.
Topics: Acidosis; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Dogs; Electrophysiology; Fatty | 1981 |
[Acetyl carnitine in the prevention of arrhythmic complications in acute myocardial infarct. Preliminary results].
Topics: Acetylcarnitine; Acute Disease; Arrhythmias, Cardiac; Carnitine; Humans; Myocardial Infarction | 1981 |
[The anti-arrhythmic effect of L-carnitine in subjects with ischemic cardiopathy].
Topics: Adult; Aged; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Electrocardiography; Female; Humans; | 1981 |
Inhibition of myocardial lysophosphatidyl choline transacylase by palmitoyl carnitine: implications for arrhythmogenesis.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acyltransferases; Animals; Arrhythmias, Cardiac; Carn | 1981 |
Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration.
Topics: Aconitine; Animals; Arrhythmias, Cardiac; Blood Glucose; Blood Pressure; Carnitine; Diabetes Mellitu | 1994 |
[Cellular electrophysiological basis of proarrhythmic and antiarrhythmic effects of ischemia-related lipid metabolites].
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Electrophysiology; Guinea Pigs; Heart; Lysophosphatidylcho | 1993 |
[Physiologic bases for the use of L-carnitine in cardiology].
Topics: Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Disease Models, Animal; Fatty Acids; Glu | 1998 |
Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenase, Long-Chain; Arrhyt | 1999 |
Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Barium; Carnitine; Coronary Circulation; Crea | 1991 |
Mechanism of arrhythmias induced by palmitylcarnitine in guinea pig papillary muscle.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Carnitine; Guinea Pigs; In Vitro Techniques; Myoca | 1989 |
Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
Topics: Acyl Coenzyme A; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Disopyramide; Dogs; Fat | 1988 |
Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 1986 |
Carnitine nutriture of dialysis patients.
Topics: Arrhythmias, Cardiac; Carnitine; Humans; Hyperlipidemias; Muscular Diseases; Nutritional Requirement | 1986 |
Antiarrhythmic and myocardial metabolic effects of verapamil during coronary artery reperfusion.
Topics: Acyl Coenzyme A; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Vessels; | 1985 |
Effects of propranolol and diltiazem on carnitine derivatives and acyl CoA in ischemic myocardium.
Topics: Acyl Coenzyme A; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Benzazepines; Carnitine; Cor | 1985 |